Terms ending in 2032
Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,580,265 | Antibody Molecules Which Bind IL-17A and IL-17F In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 9,034,600 | DNA Encoding Antibody Molecules Which Bind IL-17A and IL-17F In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 9,988,446 | Methods of Treatment Using Antibodies Which Bind IL-17A and IL-17F In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 9,925,150 | Polyvinylpyrrolidone for the Stabilization of a Solid Dispersion of the Non-Crystalline Form of Rotigotine In force · High confidence | Ucb Pharma GmbH and LTS Lohmann Therapie Systeme AG | In force | High confidence | |
| US 8,957,218 | 2-Oxo-1-Imidazolidinyl Imidazothiadiazole Derivatives In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 10,149,818 | Daily Formulation of Lacosamide In force · High confidence | Ucb Pharma GmbH | In force | High confidence | |
| US 10,487,136 | Process for Obtaining Antibodies In force · High confidence | Ucb Developed Brands SRL | In force | High confidence | |
| US 9,309,280 | Protein Purification In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 10,189,897 | Protein Purification In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| US 11,339,214 | Protein Purification In force · High confidence | Ucb Pharma, S.A. | In force | High confidence | |
| 2 more term ends in 2032 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
5 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.